LMNX
$20.22
Luminex
($.10)
(.49%)
LMNX
Earnings Whisper ®
N/A
3rd Quarter September 2019
Consensus:  ($0.07)
Revenue:  $81.63 Mil
Monday
Nov 4
4:00 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when LMNX reports earnings?
Beat
Meet
Miss

Where is LMNX's stock price going from here?
Up
Flat
Down
Stock chart of LMNX
Analysts
Summary of analysts' recommendations for LMNX
Score
Grade
Pivots
Resistance
$20.61
$20.47
$20.35

$20.21

Support
$20.09
$19.95
$19.83
Tweet
Growth
Description
Luminex Corporation has developed, manufactures and markets a proprietary technology that simplifies biological testing for the life sciences industry. This industry depends on a broad range of tests, called bioassays, to discover new drugs, identify new genes or simply monitor blood cholesterol levels. The LabMAP system simultaneously performs up to 100 bioassays on a single drop of fluid.
Peers
Alexion PharmaceuticalsIncyteExact SciencesCharles River Laboratories InternationalExelixisCoherus Biosciences